C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study

Diabetes

Volumn 51, Issue 5, 2002, Pages 1596-1600

  Freeman, Dilys J ^a,b   Norrie, John ^a   Caslake, Muriel J ^a   Gaw, Allan ^a   Ford, Ian ^a   Lowe, Gordon D O ^a   O'Reilly, Denis St J ^a   Packard, Chris J ^a   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

EID: 0036312978     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.5.1596     Document Type: Article

References (24)

1. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
2. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group
3. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
4. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
5. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians
6. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
7. Pravastatin and the development of diabetes mellitus: Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
8. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study
9. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
10. Screening experience and baseline characteristics in the West of Scotland Study
11. Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
12. The relation of markers of inflammation to the development of glucose disorders in the elderly: The Cardiovascular Health Study
13. IRS-1 mediated inhibition of the insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance
14. Mechanism of hypertriglyceridaemia induced by tumour necrosis factor administration to rats
15. Fatty acids, hyperinsulinaemia, and insulin resistance: Which comes first?
16. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease
17. The association between insulin resistance and endotheliopathy
18. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women
19. Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with type II diabetes
20. New evidence for beneficial effects of statins unrelated to lipid lowering
21. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
22. Effect of high-versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
23. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta